
TRDA Market Cap & Key Metrics
Entrada Therapeutics, Inc.
$4.64
-$0.39(-7.75%)
38
Overall
60
Value
20
Tech
34
Quality
Market Cap
$181.66M
Volume
324.95K
52W Range
$4.11 - $16.45
Target Price
$18.75
TRDA market cap is $181.66M. This page lists Entrada Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
TRDA Key Metrics
- Market cap
- $181.66M
- EPS estimate, current year
- $-4.12
- EPS growth, 3-year
- -4.74%
- Value score
- 60
- Quality score
- 34
- Technical score
- 20
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $25.42M | $210.78M | $129.01M | - | - |
| EBITDA | -$153.80M | $70.30M | $14.86M | -$95.35M | -$50.06M |
| EPS | $-3.47 | $1.76 | $-0.20 | $-3.02 | $-8.16 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TRDA | $4.64 | -7.8% | 324.95K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Entrada Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW